Abstract
It is interesting to reflect on the present growth of radionuclide brain scanning. Not so many years ago, and in particular in the mid-1970s, after the peak effect of X-ray computed tomography (CT) brain scanning, radionuclide brain studies significantly declined in frequency and clinical importance. Now, after a decade, radionuclide studies of the brain have gained renewed interest.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ackerman, R. H., Correia, J. A., Alpert, N. M. et al. (1981) Positron imaging in ischaemic stroke disease using compounds labelled with oxygen-15. Arch. Neurol., 38, 537–43.
Ancri, G., Basset, J.-Y., Leuchamp, Y. and Eavard, C. (1978) Diagnosis of cerebral lesions by thallium-201. Radiology, 128, 417–22.
Austin, G., Laffin, D., Roche, S. et al. (1973) A noninvasive i.v. isotope method for measuring cerebral blood flow. Stroke, 4, 362–3.
Bach, M. C. and Boothby, J. A. (1986) Dementia associated with human immunodeficiency virus with a negative ELISA. N. Engl.J. Med., 315, 891–2.
Baron, J. C. (1985) Positron tomography ischemia: a review. Neuroradiology, 27, 509–16.
Baron, J. C. (1987a) in Journal of Functional Imaging in Neurology and Psychiatry (eds J. Wade, S. Knezevic, V. A. Maximilian et al.), J. Libbey, pp. 91–100.
Baron, J. C. (1987b) in Clinical Efficacy of Positron Emission Tomography (eds W. D. Heiss, G. Pawlik, K. Herholz and K. Wierhard), Martinus Nijhoff, Amsterdam.
Biersack, H. J., Reichmann, K., Stefan, H. et al. (1987) SPECT: Befunde bei Epilepsie und Migrane. Nucl. Med., 26, 100–4.
Boucher, B. J. and Sear, R. (1980) A summary of the results of radioisotope brain scans on a large series of patients. Br. J. Radiol., 53, 1174–6.
Boyd, R. E., Robson, J., Hunt, F. C. et al. (1973) 99mTc gluconate complexes for renal scintigraphy. Br.J. Radiol., 46, 604–12.
Britton, K. E., Nimmon, C. C., Jarritt, P. H., Granowska, M. et al. (1977) in Advanced Medicine, Vol. 13 (ed. G. M. Besser), Pitman Medical, London, pp. 444–61.
Britton, K. E., Granowska, M., Rutland, M. et al. (1979a) in Progress in Stroke Research, Vol. 1 (eds R. M. Greenhalgh and F. C. Rose), Pitman Medical, London, pp. 307–15.
Britton, K. E., Granowska, M., Nimmon, C. C. et al. (1985) Cerebral blood flow in hypertensive patients with cerebrovascular disease. Nucl. Med. Commun., 6, 251–61.
Britton, K. E., Nimmon, C. C., Granowska, M. and Lee, T. Y. (1979b) in Information Processing in Medical Imaging, INSERM, Paris, pp. 469–86.
Britton, K. E., Granowska, M. and Nimmon, C. C. (1981) in Proceedings of the International Symposium on Medical Radionuclide Imaging, Heidelberg 1980, International Atomic Agency, Vienna.
Bruine, J. F., van Royen, E. A., Vyth, A. et al. (1985) Thallium-201 diethyldithiocarbamate: an alternative to iodine-123 N-isopropyl-p-iodoamphetamine.J. Nucl. Med., 26, 925–30.
Buell, U., Moser, E. A., Schmiedek, P. et al. (1984) Dynamic SPECT with Xe-133: regional cerebral blood flow in patients with unilateral cerebrovascular disease: concise communication.J. Nucl. Med., 25, 441–6.
Buell, U., Stirner, H., Ferbert, D. et al. (1987) Cerebral blood flow/volume-SPECT with Tc-99m labelled hexamethylpropyleneamine oxime (HMPAO) and red blood cells in cerebrovascular disease (CVD) or epilepsy (E).J. Nucl. Med., 28, 600.
Carne, C. A. (1987) Neurological manifestations: ABC of AIDS. Br. Med. J., 294, 1399–402.
Carril, J. M., MacDonald, A. F., Dendy, P. P. et al. (1979) Cranial scintigraphy: value of adding emission computed tomographic sections to conventional pertechnetate images.J. Nucl. Med., 20, 117–23.
Chase, T. N., Foster, N. L., Fedio, P. et al. (1984) Regional cortical dysfunction in Alzheimer’s disease as determined by positron emission tomography. Ann. Neurol., 15 (Suppl. S), 170–4.
Chawluk, J. B., Alavi, A., Dann, R. et al. (1987) Positron emission tomography in aging and dementia: effect of cerebral atrophy. J. Nucl. Med., 28, 431–7.
Costa, D. C., Ell, P. J., Cullum, I. D. et al. (1986a) The in vivo ditribution of 99Tcm-HMPAO in normal man. Nucl. Med. Commun., 7, 647–58.
Costa, D. C., Jones, B. E., Steiner, T. J. et al. (1986b) Relative 99mTc-HMPAO and 113Sn-microspheres distribution in dog brain. Nuklearmedizin, 25, A53.
Costa, D. C., Lui, D., Sinha, A. K. et al. (1987a) Tc-99m-d, l-HMPAO vs. Tl-201-DDC: subcellular distribution in rat brain.J. Nucl. Med., 28, 593.
Costa, D. C., Davies, P. T. G., Jones, B. E. et al. (1987b) Cerebral blood flow imaging in migraine patients with 99mTc-HM-PAO and single photon emission tomography: preliminary findings and a report on its efficacy. Adv. Headache Res., 75–80.
Costa, D. C. Ell, P. J., Stibe, C. M. A. et al. (1987c) Tc-99m-HMPAO rCBF/SPET in Parkinsonians with the ‘on-off’ syndrome: preliminary results. Nuklearmedizin, 26, 111.
Davies, K. L. and Mohs, R. C. (1986) Cholinergic drugs in Alzheimer’s disease. N. Engl. J. Med., 315, 1286–7.
DeBoulay, G. H. and Marshall, J. (1975) Comparison of E. M. I. and radioisotope imaging in neurological disease. Lancet, ii, 1294–7.
De Roo, M., Mortelmans, L., Devos, P. et al. (1987) Clinical experience with Tc-99m-HMPAO high resolution SPECT of the brain in patients with cerebrovascular disease. Nuklearmedizin, 26, 148.
Di Chiro, G., Ommaya, A. K., Ashbvurn, W. L. and Briner, W. H. (1968) Isotope cisternography in the diagnosis and follow up of cerebrospinal fluid rhinorrhoea.J. Neurosurg., 28, 522–9.
Drayer, B. P., Wilkins, R. H., Boehnke, M. et al. (1977) Cerebrospinal fluid rhinorrhoea demonstrated by metrizamide CT cisternography. Am. J. Roentgenol, 129, 149–51.
Ell, P. J., Deacon, J. M. and Jarritt, P. H. (1980) Atlas of Computerized Emission Tomography, Churchill Livingstone, Edinburgh.
Ell, P. J., Harrison, M. and Lui, D. (1983) Cerebral blood flow with iodine-123 labelled amines. Lancet,ii, 1348–52.
Ell, P. J., Cullum, I., Costa, D. C. et al. (1985a) A new regional cerebral blood flow mapping with 99Tcm-labelled compound. Lancet, ii, 50–1.
Ell, P. J., Hocknell, J. M. L., Jarritt, P. H. et al. (1985b) A 99Tcm-labelled radiotracer for the investigation of cerebral vascular disease. Nucl. Med. Commun., 6, 437–41.
Ell, P. J., Cullum, I. D., Lui, D. et al. (1987a) in Journal of Functional Imaging in Neurology and Psychiatry (eds J. Wade, S. Knezevic, V. A. Maximilian et al.), John Libbey, pp. 54–70.
Ell, P. J., Costa, D. C., Cullum, I. et al. (1987b) The Clinical Application of rCBF Imaging by SPECT. Amersham, Little Chalfont, UK.
Ell, P. J., Costa, D. C. and Harrison, M. (1987c) Imaging cerebral damage in HIV infection. Lancet, i, 569–70.
Frackowiak, R. S. J., Pozzilli, C., Legg, N. J. et al. (1981) Regional cerebral oxygen supply and utilization in dementia: a clinical and physiological study with oxygen-15 and positron tomography. Brain, 104, 753–78.
Gemmell, H. G., Sharp, P. F., Evans, N. T. S. et al. (1984) Single photon emission tomography with 123I-isopropyleamphetamine in Alzheimer’s disease and multi-infarct dementia. Lancet, ii, 1348.
George, R. O. and Wagner, H. N. (1975) in Non-Invasive Brain Imaging (eds H. J. DeBlanc and J. A. Sorenson), Society of Nuclear Medicine, New York, pp. 3–23.
Gibbs, J. M., Wise, R. J. S., Leeuders, K. L. and Jones, T. (1984) Evaluation of cerebral perfusion reserve in patients with carotid artery occlusion. Lancet, i, 310–14.
Granowska, M., Britton, K. E., Afshar, F. et al. (1980) Total and regional cerebral flow non-invasive quantitation in patients with subarachnoid haemorrhage.J. Neurosurg., 53, 153–9.
Gray, W. R., Hickey, D., Parkey, R. W. et al. (1979) Clinical Nuclear Cardiology (eds R. W. Parkey, F. J. Bonte, L. M. Buja and J. T. Willerson), Appleton Century Crofts, New York, pp. 297–308.
Gustafson, L., Brun, A. and Ingvar, D. H. (1977) in Cerebral Vascular Disease (eds J. D. Meyer, H. Lechner and M. Reivich), Excerpta Medica, Amsterdam, pp. 5–9.
Hackinski, V. (1978) Cerebral blood flow: differentiation of Alzheimer’s disease and multi-infarct dementia, in Alzheimer’s Disease: Senile Dementia and related disorders (eds R. Katzman, R. D. Terry and K. L. Bick) Raven Press, New York, pp. 97–103.
Hauser, W. et al. (1970) Technetium-99m DTPA: a new radiopharmaceutical for brain and kidney scanning. Radiology, 94, 679.
Hill, T. C., Holman, L., Lovett, R. et al. (1982) Initial experience with SPECT (single photon computerised tomography) of the brain using N-isopropyl-I-123 p-iodoamphetamine: concise communication.J. Nucl. Med., 23, 3.
Hill, T. C., Magistretti, P. L. Holman, B. L. et al. (1984) Assessment of regional cerebral blood flow (rCBF) in stroke using SPECT and N-isopropyl-(I-123)-p-iodoamphetamine (IMP), Stroke, 40–5.
Holm, S., Andersen, A. R., Vorstrup, S. et al. (1985) Dynamic SPECT of the brain using a lipophilic technetium-99m complex, PnAO. J. Nucl. Med., 26, 1129–34.
Holman, B. L., Hellmon, R. S., Goldsmith, S. J. et al. (1989) Biodistribution, dosimetry and clinical evaluation of Technetium 99m ethyl cysteinate driver in normal subjects and in patients with chronic cerebral infarction.J. Nucl. Med., 30, 1018–24.
Ingvar, D. H. (1975) Brain work: Alfred Benzon Symposium VIII (eds D. H. Ingvar and N. A. Lassen), Munksgaard, Copenhagen, pp. 397–413.
Ingvar, D. H. and Lassen, N. A. (1961) Quantitative determination of regional cerebral blood flow in man. Lancet, ii, 806–7.
Ingvar, D. H. and Risberg, J. (1965) Influence of mental activity upon regional cerebral blood flow in man. Acta Neurol. Scand., 41 (Suppl. 43), 42–73.
Ingvar, D. H. and Risberg, J. (1967) Increase of regional cerebral blood flow during mental effort in normals and in patients with focal brain disorders. Exp. Brain Res., 3, 195–211.
Ingvar, D. H., Risberg, J. and Schwartz, M. S. (1975) Evidence of subnormal function of association cortex in presenile dementia. Neurology, 10, 964–74.
Jarritt, P. H., Ell, P. J., Myers, M. J. et al. (1979) A new transverse section brain imager for single gamma emitters.J. Nucl. Med., 20, 319–27.
Keeling, F., Babich, J., Flower, M. A. et al. (1986) Early experience with 99TcmHMPAO in patients with brain tumours. Nucl. Med. Commun., 7, 274.
Kety, S. S. and Schmidt, C. F. (1945) The determination of cerebral blood flow in man by use of nitrous oxide in low concentrations. Am. J. Phys., 143, 53–66.
Knapp, W. H., von Kummen, R. and Kubler, W. (1986) Imaging of cerebral blood flow to volume distribution using SPECT.J. Nucl. Med., 27, 465–70.
Kung, K. F., Pan, S., Kung, M. P., Billings, J., Kasliwal, R., Reilley, J., Alavi, A. (1989) In vitro and In vivo evaluation of 123I-IBZM. A potential CNS D-2 dopamine receptor imaging agent. J. Nucl. Med., 30, 88–92.
Kung, H. F., Tramposch, K. M. and Blau, M. (1983) A new brain perfusion imaging agent: N, N, N′-trimethyl-N′ -(2-hydroxy-3-methyl-5-iodobenzyl)-1, 3 propanediamine (HIPDM).J. Nucl. Med., 24, 66–72.
Langen, K.-J., Roosen, N., Kuwert, T. et al. (1987) 99mTc-HMPAO SPECT in the study of cerebral tumours: results in 40 patients. Nuklearmedizin, 26, 118.
Lassen, N. A. (1966) The luxury perfusion syndrome and its possible relation to acute metabolic acidosis localised within the brain. Lancet, ii, 1113–15.
Lassen, N. A. and Munck, O. (1955) The cerebral blood flow in man determined by the use of radioactive krypton. Acta Phys. Scand., 33, 30.
Lassen, N.A., Roland, P. E., Larsen, B. et al. (1977) Mapping of human cerebral functions: a study of the regional cerebral blood flow pattern during rest, its reproducibility and the activations seen during basic sensory and motor functions. Acta Neurol. Scand., 56 (Suppl. 64), 262–3.
Lassen, N. A., Henriksen, L. and Paulson, O. (1981) Regional cerebral blood flow in stroke by 133xenon inhalation and emission tomography. Stroke, 12, 3.
Lauritzen, M. (1987) in Journal of Functional Imaging of Neurology and Psychiatry (eds J. Wade, S. Knezevic, V. A. Maximilian et al.), John Libbey, London.
Lenzi, G. L., Frackowiak, R. S. J. and Jones, T. (1982) Cerebral oxygen metabolism and blood flow in human cerebral ischemic infarction.J. Cereb. Blood Flow Metab., 2, 321–35.
Leonard, J.-P., Nowotnik, D. P. and Neirinckx, R. D. (1987) Technetium-99m-d, l-HM-PAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT: a comparison with iodine-123 HIPDM.J. Nucl. Med., 27, 1819–1823.
Lucignani, C., Nehlig, A., Blasberg, R. et al. (1985) Metabolic and kinetic considerations in the use of 125I-HIPDM for quantitative measurement of regional cerebral blood flow.J. Cereb. Blood Flow Metab., 5, 86–96.
Mallet, B. L. and Veall, N. (1965) The measurement of regional cerebral clearance rates in man using xenon-133 inhalation and extracranial recording. Clin. Sci., 29, 179–91.
Matsuda, H., Seki, H., Sumiya, H. et al. (1986) Quantitative cerebral blood flow measurements using N-isopropyl-(iodine-123)p-iodoamphetamine and single photon emission computed tomography with rotating gamma camera. Am. J. Phys. Imaging, 1, 186–94.
Maximilian, V. A., Prohovnik, I., Risberg, J. and Hakansson, K. (1978) Regional blood flow changes in the left cerebral hemisphere during word pair learning and recall. Brain Lang., 6, 22–31.
Maziere, B. and Maziere, M. (1990) Where have we got to with neuroreceptor mapping of the human brain? European Journal of Nuclear Medicine, 16, no. 11, 817–837.
Mazziotta, J. C. and Phelps, M. E. (1986) in Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart (eds M. Phelps, J. Mazziotta and H. Schelbert), Raven Press, New York, pp. 493–570.
Meurman, O. H., Irjal, K., Suonpaa, J. and Laurent, B. (1979) A new method for the identification of cerebrospinal fluid leakage. Acta Otolaryngol, 87, 366–9.
Moretti, J. L., Defer, G., Cesaro, P. et al. (1985) Early and late SPECT with n-isopropyl-p-iodoamphetamine-I-123 (IAMP) in cerebral ischaemia. Eur. J. Nucl. Med., 11 (suppl.): A24.
Moretti, J. L., Cinotti, L., Cesaro, P. et al. (1987) Amines for brain tomoscintigraphy. Nucl. Med. Commun., 8, 581–95.
Moses, D. C., Natarajan, T. K., Previosi, T. J. et al. (1973) Quantitative cerebral circulation studies with sodium pertechnetate.J. Nucl. Med., 14, 142–8.
Mueller, S. P., Johnson, K. A., Hamil, D. et al. (1986) Assessment of I-123 IMP SPECT in mild/moderate and severe Alzheimer’s disease.J. Nucl. Med., 27, 889.
Nagle, C.E. (1980) Use of immediate static scans in combination with radionuclide cerebral angiography as a confirmatory test in the diagnosis of brain death. Clin. Nucl. Med., 5, 152–3.
Navia, B. A., Jordan, B. D. and Price, R. W. (1986a) The AIDS dementia complex: I. Clinical features. Ann. Neurol., 19, 517–24.
Navia, B. A., Cho, E.-S., Petito, C. K. et al. (1986b) The AIDS dementia complex: II. Neuropathology. Ann. Neurol., 19, 525–35.
Neirinckx, R. D., Canning, L. R., Piper, I. M. et al. (1987) Technetium-99m d, l-HM-PAO: a new radiopharmaceutical for SPEC imaging of regional cerebral blood perfusion.J. Nucl. Med., 29, 191–202.
Obrist, W. D., Thomson, H. K., Wang, H. S. and Wilkinson, W. E. (1975) Regional cerebral blood flow activated by 133Xe-inhalation. Stroke, 6, 245–56.
Oldendorf, W. H. (1975) in Non-invasive Brain Imaging (eds H. J. De Blanc and J. A. Sorenson), Society of Nuclear Medicine, New York, pp. 17–23.
Olesen, J. (1971) Contralateral focal increase of cerebral blood flow in man during arm work. Brain, 94, 635–46.
Potchen, E. J. and McCready, V. R. (1972) Neuronuclear medicine. Prog. Nucl. Med., 1, 2.
Potchen, E. J., Holman, B. L. Evans, R. G. et al. (1971) in Proceedings of the 4th International Symposium in Brain and Blood Flow (ed. R. W. R. Russell), Pitman, London, pp. 94–7.
Prohovnik, I., Hakansson, K. and Risberg, J. (1980) Observations on the functional significance of regional blood flow in ‘resting’ normal subjects. Neuropsychologia, 18 (2), 203–17.
Razzak, M. A., Muddaris, F. and Christie, J. H. (1980) Sensitivity of radionuclide brain scan imaging and computerized axial tomography in detecting subdural haematoma. Clin. Nucl. Med., 5, 154–8.
Riccio, M. (1987) Aids and dementia. Br. J. Hosp. Med., 11 July, 38, 11.
Risberg, J. (1987) in Journal of Functional Imaging in Neurology and Psychiatry (eds J. Wade, S. Knezevic, V. A. Maximilian et al.), John Libbey, London, pp. 35–43.
Risberg, J. and Ingvar, D. H. (1972) Multibolus technique for measuring the distribution of cerebral blood flow over short intervals in man. Circ. Res., 31, 889–98.
Risberg, J., Halsey, J. H., Wills, E. L. and Wilson, E. M. (1975) Hemispheric specialization in normal man studied by bilateral measurements of the regional cerebral blood flow: a study with the 133-Xe inhalation technique. Brain, 98, 511–24.
Risberg, J., Maximilian, A. V. and Prohovnik, I. (1977) Changes of cortical activity patterns during habituation to a reasoning test: a study with the 133Xe inhalation technique for measurement of regional cerebral blood flow. Neuropsychologia, 15, 793–8.
Roine, R. O., Launes, J., Lindroth, L. and Nikkinen, P. (1986) 99mTc-hexamethylpropyleneamine oxime scans to confirm brain death. Lancet, ii, 1223–4.
Rossor, M. (1987) Dementia. Br. J. Hosp. Med., 38, 46–50.
Royal, H. O., Hill, Th. C. and Holman, B. L. (1985) in Seminars in Nuclear Medicine XV (eds L. M. Freeman and M. D. Blaufox), Grune and Stratton, New York, pp. 357–76.
Rutland, M. D., Lee, T. Y., Nimmon, C. C. et al. (1980) Measurement of the effects of a single dose of Prazosin on the cerebral blood flow in hypertensive patients. Postgrad. Med. J., 56, 818–22.
Schall, G. L., Zeiger, L. S. and Di Chino, G. (1971) Clinical comparison of 2 99mTc tracers for brain scanning: pertechnetate versus labelled albumin. Radiology, 99, 361–8.
Sharp, P. F., Smith, F. W., Gemmell, H. G. et al. (1986) Technetium-99m HMPAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J. Nucl. Med., 27, 171–7.
Shields, R. A., Burjon, A. W., Prescott, M. C. et al. (1986) Tc-99m-HMPAO: a new brain imaging agent: biodistribution studies and initial clinical trials in dementia. Nucl. Med. Commun., 7, 284–5.
Suess, E., Podreka, I., Goldenberg, G. et al. (1986) Initial experience with 99Tcm-hexamethylpropylene-amineoxime brain SPECT. Nucl. Med. Commun., 7, 285.
Suess, E., Podreka, I., Baumgartner, Ch. et al. (1987) 99Tcm-HMPAO brain SPECT in partial complex seizures. Nucl. Med. Commun., 8, 240.
Summers, W. K., Majovski, L. V., Marsh, G. M. et al. (1986) Oral tetrahydroaminoacridine in long term treatment of senile dementia, Alzheimer type. N. Engl. J. Med., 315, 1241–5.
Symon, L. and Dorsch, N. W. C. (1975) Use of long term intracranial pressure measurement to assess hydrocephalic patients prior to surgery.J. Neurosurg., 42, 258–73.
Testa, H. J., Shields, R. A., Burjan, A. W. I. et al. (1987) Investigation of dementia using 99Tcm-HMPAO and single photon emission tomography. Nucl. Med. Commun., 8, 241.
Tramposch, K. M., Kung, H. F. and Blau, M. (1980) Brain imaging with 1–123 labelled amines for brain studies: localisation of 1–123 iodophenylakyl amines in rat brain.J. Nucl. Med., 21, 940–6.
Vallabhajosula, S., Zimmermon, R. E., Micord, M. et al. (1989) Technetium-99m ECD: A new brain imaging agent: In vivo kinetics and biodistribution studies in normal subjects.J. Nucl. Med., 30, 599–604.
Van Duyl, W. A. and Volkers, A. C. W. (1980) Measurement of cerebral blood flow in the pig by Xe-133 clearance technique: failure of the two compartmental clearance model. Eur. J. Nucl. Med., 5, 86–96.
Vangelista, R., Visentin, E., Dalla Pozza, F. et al. (1987) Brain SPECT with 99mTc-labelled hexamethyl propylene amine oxime (99mTc-HM-PAO): our experience.J. Nucl. Med. Allied Sci., 31, 166.
Van Horn, G. (1987) Dementia. Am. J. Med., 83, 101–10.
Verhoeff, N. P. L. G., Bobeldijk, M., Van Royen, E. A., Feenstra, M. G. P., Boer, G. J., Van Doremalen, P.A.P.M. (1989) In Vitro and In Vivo binding of dopamine D2 receptors with 123I-Iodobenzamide in rat brain. Pharmaceutisch Weekblad Scientific Edition, 11, Suppl. J: J13.
Verhoeff N. P. L. G., Van Royen, E. A., Costa, D. C., Cullum, I. D., Lui, D., Ell, P. J., Sved, G. M. S., Barrett, J. J., Toone, B. (1990) A study of the dopamine D2 receptor in human brain with 123I-IBZM SPET. Nucl. Med. Commun., 3, 246.
Volkert, W. A., Hoffman, T. J., Seger, R. M. et al. (1984) Tc-99m propylene amine oxime (Tc-99m-PnAO): a potential brain radiopharmaceutical. Eur. J. Nucl. Med., 9, 511–16.
Winchell, H. S., Horst, W. D., Braun, L. et al. (1980) N-Isopropyl (iodine-123) p-iodoamphetamine: single paps brain uptake and washout: binding to brain synaptosomes and localisation in dog and monkey brain. J. Nucl. Med., 21, 947–52.
Wise, R. J. S., Bernardi, S., Frackowiak, R. S. J. et al. (1983) Serial observations on the pathophysiology of acute stroke: the transition from ischaemia to infarction as reflected in regional oxygen extraction. Brain, 106, 197–222.
Woolley, J. L., Williams, B. and Ventakesh, S., (1977) Cranial isotope section scanning. Clin. Radiol., 28, 517–28.
Further Reading
Editorial (1989) SPECT and PET in epilepsy, Lancet, i, 135–7.
Kung, H. F. (1990) New technetium-99m labelled brain perfusion imaging agents, Semin. Nucl. Med., 20, 150–8.
Maziere, B. and Maziere, M. (1990) Where have we got to with neuroceptor mapping of the human brain?, Eur. J. Nucl. Med., 16, 817–35.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Ell, P.J., Britton, K.E. (1991). The brain. In: Maisey, M.N., Britton, K.E., Gilday, D.L. (eds) Clinical Nuclear Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3358-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-4899-3358-4_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-27900-3
Online ISBN: 978-1-4899-3358-4
eBook Packages: Springer Book Archive